Project Grant R01HL172349
Award Date
5/1/25
Completion Date
4/30/30
Dollars Obligated
$671K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This federal Project Grant award of $2,428,701 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports a comprehensive, prospective evaluation of 1,000 pregnant individuals with cardiovascular disease (CVD) across 33 partner sites. The study aims to: Identify patient characteristics associated with adverse pregnancy outcomes, maternal adverse cardiac events, neonatal adverse clinical events, and quality of life, with a focus on racial...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $696,470 to the University of Denver to conduct research on the impact of prenatal maternal sleep on offspring cardiovascular disease risk. The 5-year project will objectively measure maternal sleep patterns across pregnancy and evaluate how they relate to maternal biological processes (stress, inflammation), infant growth and adiposity,...
This $734,463 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to advance the treatment of peripheral artery disease (PAD) through two primary objectives: Establish a novel MRI-based anatomic scoring system to better predict which patients are likely to experience immediate technical failure of percutaneous vascular interventions (PVI) procedures, in order to improve patient selection for PVI....
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded Pyrames Inc. a $242,313 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837). The funding will support the development of Pyrames' non-invasive, continuous blood pressure monitoring device for prenatal maternal healthcare. The project aims to extend Pyrames' platform, which uses capacitive pulse sensing and machine learning techniques, to accurately measure...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $869,696 to Vanderbilt University Medical Center (VUMC) to conduct a large prospective study investigating the hypothesis that preeclampsia leads to persistent cardiovascular changes that mirror early heart failure with preserved ejection fraction (HFPEF). The key objectives are to: 1) measure the relationship between...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $456,251 to Colorado State University (CSU) to investigate the role of maternal obesity and inflammation in the development of preeclampsia and its long-term impacts on offspring cardiometabolic health. The overarching goal is to test the hypothesis that pro-inflammatory factors produced by maternal...
This federal Project Grant award, valued at $727,080 and awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), will support research to investigate the neurogenic mechanisms underlying the relationship between psychosocial stress, postpartum cardiovascular disease, and postpartum depression. The key objectives are to determine if mitochondrial stabilization in the medial prefrontal cortex can prevent stress-induced...
This Project Grant award, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to investigate the relationship between maternal obesity, gut microbiome, and cardiovascular disease in offspring. The $250,000 award supports a 4-year study at Colorado State University to determine if maternal gut dysbiosis and inflammatory signaling contribute to abnormal fetal programming and the development of cardiometabolic...
This $171,450 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports a multi-omic investigation into the biological mechanisms linking excess body fat (adiposity) and elevated blood lipid levels as contributors to cardiovascular disease risk. The research, led by Dr. Dron at the Massachusetts General Hospital, aims to: (1) measure the interaction effects between adiposity and genetic factors on...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $647,174 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The Miriam Hospital Lifespan Division to investigate the long-term effects of prenatal mindfulness training on maternal and infant cardiovascular disease risk. This 5-year research project will follow 130 participants and their infants enrolled in a parent RCT study to measure the impact of prenatal mindfulness training on postpartum...